Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- CROSSJECT and BARDA align ZEPIZURE®’s Pediatric development plan with FDA including funding through 2030CROSSJECT and BARDA align ZEPIZURE®’s Pediatric development plan with FDA including funding through 2030
- OracleReal-World Data and AI Capabilities in Oracle Life Sciences Data Intelligence Help Accelerate Clinical Research and CommercializationCompanies: Oracle CorporationOracle Life Sciences Data Intelligence1 now combines real-world data, domain-trained AI capabilities, and advanced analytics in a single connected...
- OracleOracle and Buck Institute for Research on Aging Advance Landmark Federal Aging Research InitiativeCompanies: Oracle CorporationOracle Health and Life Sciences Summit -- Oracle and the Buck Institute for Research on Aging are collaborating to advance intelligence into...
- OracleOracle Health Advances Revenue Cycle Management with AICompanies: Oracle CorporationOracle Health and Life Sciences Summit -- Oracle Health today announced new AI capabilities across its revenue cycle management portfolio that are...
- Blue Cross and Blue Shield of IllinoisBlue Cross and Blue Shield of Illinois Awards $4.4M+ in Blue Impact(SM) GrantsFunding supports 121 programs advancing health and well-being across Illinois — Blue Cross and Blue Shield of Illinois is proud to award nearly $4.5 million in 2026-2027 Blue Impact grants to 121 community-based organizations. These non-profits work...
- Fogg Law GroupFogg Law Group Secures $7.6 Million Jury Verdict in Lee County Medical Malpractice CaseFogg Law Group obtained a $7.6 million verdict for their client, Rebecca Knowles. The Lee County medical malpractice case centered around a failure to recognize and treat a vascular injury secondary to a knee dislocation....
- Allegheny Health NetworkAHN Names Surgical Oncologist Dr. Matthew Holtzman as Chief Surgical Officer for its Western RegionDr. Holtzman, a highly accomplished physician leader from UPMC, will direct surgical business development and operations for new Heritage Valley footprint — Allegheny Health Network (AHN) today announced that Matthew P. Holtzman, MD, FACS, an...
- Academy of Nutrition & DieteticsAcademy of Nutrition and Dietetics Advances National Focus to Strengthen Nutrition Education in Medical SchoolsInitiative connects medical schools with nutrition expertise, practical resources and flexible models to move nutrition education from priority to practice — The Academy of Nutrition and Dietetics (the Academy), in collaboration with the Accreditation...
- OMP and PwC Alliance Moves Process Manufacturers from Siloed Supply Chain Planning to Unified DecisionsANTWERPEN, BELGIUM, Sept 23, 2026 - OMP and PwC have formed an alliance to bring unified, faster supply chain decisions to process manufacturers in life sciences, consumer goods, and chemicals. Planning in these industries runs on campaign production, long lead times, and regulatory requirements, all surfacing "too late to act on" when planning sits in separate systems. The alliance combines Unison Planning™, OMP's AI-enabled planning platform with built-in industry expertise, and PwC's implementation services. German specialty pharmaceutical company medac is already live under the alliance, with its planners working on a single demand plan in Unison Planning™. PwC and medac will present the project on October 15, 2026, at the OMP Conference in Singapore, detailing the approach behind the rollout and what it means for planning in pharma. Combining innovation, industry knowledge, and integration OMP and PwC run each implementation as a single program. OMP brings Unison Planning™, its AI-enabled platform with built-in industry expertise, connecting to the systems that a manufacturer already runs. PwC's teams lead the implementation, acting as system integrator and working directly alongside the customer's own planners. Both organizations see the same shift across life sciences, consumer goods, and chemicals: manufacturers replacing fragmented planning with a unified end-to-end plan, and looking for a platform and an implementation team that already know their industry. "Process manufacturers face the same planning constraints, whatever their size, and few have spare program capacity to absorb an implementation. That is where the combination of the platform, the industry knowledge, and an integrator who can run the program matters most," said Dieter Sleeuwaert, Senior Vice President Global Alliances at OMP. medac moves from spreadsheets to a single demand plan medac supplies specialty treatments in rheumatology, urology, hematology, and oncology to more than 90 countries, manufacturing at its own European sites. Its planning ran on a mix of spreadsheets, planning functions within its existing ERP system, and a separate tool with limited planning capability. Processes also differed by department and by geography. PwC, medac and OMP started with a focused demand planning release, resulting in an accelerated go-live for German planners ahead of the wider rollout. The remaining geographies, a supply planning layer, and a second release running in parallel with medac's SAP S/4 implementation will follow. "Leading with the demand planning release and holding the solution close to standard is what made it work. That approach transfers to other companies in the sector," said Jörg Zietz, Director, Supply Chain Planning at PwC Germany. PwC and medac on stage in Singapore Dr. Karsten Gentner, Vice President Supply Chain Management and Procurement at medac, and Jörg Zietz of PwC Germany will explain how medac is building the digital backbone for a smarter, more resilient, and AI-ready pharmaceutical supply chain. Their session takes place on October 15, 2026 at the OMP Conference in Singapore. Register for the event. About PwC At PwC, we help clients build trust and reinvent so they can turn complexity into a competitive advantage. We're a tech-forward, people-empowered network with more than 364,000 people in 136 countries and 137 territories. Across audit and assurance, tax and legal, deals and consulting, we help clients build, accelerate, and sustain momentum. About medac The medac Group is committed to improving patients' quality of life worldwide by providing access to the best possible medical therapies. As a globally operating pharmaceutical company headquartered in Germany, we are active in more than 90 countries and employ over 2,000 people worldwide. With production sites in Europe and a focus on rheumatology, urology, hematology, and oncology, medac develops and markets high-quality originator products, generics, and biosimilars. About OMP OMP helps companies facing complex planning challenges to excel, grow, and thrive by offering the best digitized supply chain planning solution on the market. Hundreds of customers in a wide range of industries - spanning consumer goods, life sciences, chemicals, metals, paper, packaging, plastics, tires, and building products - benefit from using OMP's unique Unison Planning™. Solution and product inquiries Contact OMP +32 3 650 22 11 Media inquiries Kira Perdue (Carabiner) SOURCE: OMP
- CON-CRĒTCON-CRĒT® Creatine HCl Rolls out Major Retail Expansion into Target and CVSCompanies: CVS HealthAs creatine goes mainstream, CON-CRĒT® brings its #1 absorbed formula to more health-conscious consumers — CON-CRĒT® Creatine HCl, the original high solubility creatine and the molecule that was awarded more patents than any other creatine,...
- WellWithAllWellWithAll Names Five Finalists for $1 Million Prize Competition Scaling AI Health Innovations NationwideThese top breakthroughs stand out for their potential to help nearly 6 million of the people the healthcare system reaches last, addressing critical healthcare gaps, including access, communication and monitoring. BOSTON, Sept. 23, 2026 -- The breakthrough isn't coming. It's...
- Monogram Health Appoints James Lim as Chief Technology OfficerSeasoned technology executive from AWS joins Monogram to lead its proprietary AI-enabled operations platform to further enhance treatment and care for its complex patient population